Effect of Silymarin in Metastatic Colorectal Cancer Patients
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
this work is aim to assess the antitumor effect of silymarin in patients with metastatic
colorectal cancer receiving chemotherapy with or without target therapy (Bevacizumab).